Use of Potentially Inappropriate Medications for People with Diabetes as a Confounding Factor in Alzheimer's Diagnosis: An Analysis Using the ADNI Database
Findings may indicate that PIMs, widely used by older adults with diabetes, have the potential to influence cognitive outcomes and Alzheimer's biomarkers, emphasizing the need for rational prescribing in vulnerable populations. This study contributes to improving differential diagnosis and promoting safer pharmacotherapeutic practices in older adults with diabetes.
Authors
- Agnes Nogueira Gossenheimer (ORCID: https://orcid.org/0000-0002-7424-8426)
- Taiane Santos Garcia (ORCID: https://orcid.org/0000-0001-8270-157X)
- Lucas Uglione Da Ros
- Sheyla Velasques Paladini
- João Pedro Ferrari‐Souza
- Eduardo R. Zimmer
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_105637
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00